Antibody-drug conjugate (ADC): Navigating complex cancer therapy development
3 October 2024
Break through with a trusted partner
Our support of an ADC-targeted chemotherapy and CDx enabled a sponsor to optimize global trial design and patient selection, ultimately achieving regulatory approval for a new cancer treatment.
Empower your ADC therapy
Case study
Find out how specialized global laboratory support and scientific expertise helped a sponsor navigate complexities in ADC development.
Brochure
Get comprehensive support for your ADC, from discovery through post-commercialization.
ADC
Your ADC journey begins with a vision—one where your drug candidate makes a profound impact on the lives of oncology patients.
Oncology
Your mission is to transform oncology patient care. Our commitment is to help you do it better, faster and more efficiently.